HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daiming Fan Selected Research

histocompatibility antigen 37

9/2017MGr1-Antigen/37 kDa laminin receptor precursor promotes cellular prion protein induced multi-drug-resistance of gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daiming Fan Research Topics

Disease

175Neoplasms (Cancer)
05/2022 - 01/2002
164Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2002
69Neoplasm Metastasis (Metastasis)
12/2022 - 03/2004
40Hepatocellular Carcinoma (Hepatoma)
01/2022 - 03/2006
33Carcinogenesis
01/2020 - 08/2002
27Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 06/2008
27Hemorrhage
01/2022 - 01/2011
23Fibrosis (Cirrhosis)
01/2022 - 01/2011
23Thrombosis (Thrombus)
01/2022 - 02/2010
16Hepatic Encephalopathy
01/2022 - 06/2010
16Hypoxia (Hypoxemia)
11/2019 - 08/2004
15Carcinoma (Carcinomatosis)
12/2011 - 04/2002
12Portal Hypertension
05/2022 - 11/2010
12Ascites
01/2022 - 01/2011
11Adenocarcinoma
12/2016 - 11/2002
11Liver Cirrhosis (Hepatic Cirrhosis)
01/2016 - 08/2007
10Colonic Neoplasms (Colon Cancer)
01/2019 - 06/2008
8Budd-Chiari Syndrome (Budd Chiari Syndrome)
01/2019 - 03/2013
8Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 01/2008
6Liver Diseases (Liver Disease)
01/2019 - 12/2013
6Esophageal Neoplasms (Esophageal Cancer)
01/2019 - 06/2010
6Infections
01/2017 - 08/2008
6Lymphatic Metastasis
07/2016 - 02/2008
5Inflammation (Inflammations)
01/2018 - 01/2009
4Liver Neoplasms (Liver Cancer)
01/2018 - 12/2013
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2017 - 10/2011
4Prion Diseases (Transmissible Spongiform Encephalopathies)
09/2017 - 06/2007
3Gastritis
01/2022 - 01/2005
3Non-alcoholic Fatty Liver Disease
10/2020 - 05/2010
3Pancreatitis
01/2019 - 07/2012
3Adenoma (Adenomas)
07/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

80Proteins (Proteins, Gene)FDA Link
05/2022 - 01/2002
44MicroRNAs (MicroRNA)IBA
03/2021 - 07/2008
36Pharmaceutical PreparationsIBA
01/2019 - 07/2002
30Small Interfering RNA (siRNA)IBA
08/2014 - 06/2004
29Biomarkers (Surrogate Marker)IBA
04/2021 - 01/2010
20Biological ProductsIBA
12/2022 - 09/2002
20Messenger RNA (mRNA)IBA
12/2022 - 04/2002
16Doxorubicin (Adriamycin)FDA LinkGeneric
06/2015 - 07/2002
15Vincristine (Oncovin)FDA LinkGeneric
06/2015 - 07/2002
13Monoclonal AntibodiesIBA
12/2022 - 01/2005
13AntigensIBA
11/2017 - 02/2005
11CytokinesIBA
01/2019 - 01/2002
11Peptides (Polypeptides)IBA
12/2012 - 02/2005
10Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2012
9LigandsIBA
01/2022 - 03/2006
9DNA (Deoxyribonucleic Acid)IBA
01/2019 - 04/2006
9Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2010 - 08/2002
8Sorafenib (BAY 43-9006)FDA Link
10/2020 - 08/2012
8Prion ProteinsIBA
09/2017 - 01/2005
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2013 - 01/2002
8Member 1 Subfamily B ATP Binding Cassette TransporterIBA
06/2010 - 04/2004
7Long Noncoding RNAIBA
12/2022 - 01/2014
7Carrier Proteins (Binding Protein)IBA
01/2019 - 09/2002
7multidrug resistance-associated protein 1IBA
08/2013 - 08/2005
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012 - 08/2004
7beta CateninIBA
10/2011 - 03/2006
7Cyclin D1IBA
06/2010 - 01/2002
6Cetuximab (Erbitux)FDA Link
12/2022 - 11/2016
6RNA (Ribonucleic Acid)IBA
02/2022 - 08/2008
6alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2017 - 07/2009
6AgarIBA
06/2017 - 08/2004
6EpitopesIBA
05/2013 - 02/2005
6S100 Calcium Binding Protein A6IBA
10/2011 - 09/2002
5Cadherins (E-Cadherin)IBA
01/2019 - 06/2007
5Indicators and Reagents (Reagents)IBA
06/2017 - 09/2007
5VaccinesIBA
01/2014 - 03/2002
4LuciferasesIBA
11/2021 - 05/2007
4BilirubinIBA
06/2020 - 09/2014
4Carcinoembryonic AntigenIBA
11/2017 - 12/2011
4human MGr1-antigenIBA
09/2017 - 01/2002
4Interleukin-6 (Interleukin 6)IBA
01/2017 - 01/2002
4Interleukin-8 (Interleukin 8)IBA
10/2015 - 01/2002
4GTP Phosphohydrolases (GTPases)IBA
08/2014 - 08/2004
4SurvivinIBA
10/2013 - 04/2008
4Complementary DNA (cDNA)IBA
02/2013 - 06/2008
4OsteopontinIBA
11/2012 - 02/2007
4hepatitis B virus X proteinIBA
09/2012 - 05/2007
4Ribosomal Proteins (Ribosomal Protein)IBA
02/2011 - 06/2004
4Proteasome InhibitorsIBA
07/2010 - 04/2008
4Phosphotransferases (Kinase)IBA
02/2010 - 10/2005
4Cisplatin (Platino)FDA LinkGeneric
09/2009 - 07/2002
4ZincIBA
08/2007 - 04/2004
3BerberineIBA
10/2020 - 11/2016
3factor V LeidenIBA
07/2020 - 10/2011
3Prothrombin (Factor II)IBA
07/2020 - 11/2014
3Etoposide (VP 16)FDA LinkGeneric
01/2020 - 08/2006
3InterleukinsIBA
01/2020 - 10/2015
3Monomeric GTP-Binding ProteinsIBA
01/2020 - 08/2004
3Propranolol (Inderal)FDA LinkGeneric
01/2019 - 03/2014

Therapy/Procedure

69Therapeutics
01/2022 - 02/2005
33Surgical Portasystemic Shunt (Portosystemic Shunt)
05/2022 - 02/2010
32Drug Therapy (Chemotherapy)
01/2022 - 01/2004
30Transjugular Intrahepatic Portasystemic Shunt
05/2022 - 11/2010
14Stents
01/2022 - 11/2010
6Immunotherapy
01/2022 - 01/2002
6Gastrectomy
11/2017 - 01/2014
4Transplantation
01/2019 - 07/2008
4Fecal Microbiota Transplantation
10/2017 - 01/2015
3Ligation
01/2019 - 08/2017